U.S. markets closed
  • S&P 500

    4,594.62
    -106.84 (-2.27%)
     
  • Dow 30

    34,899.34
    -905.06 (-2.53%)
     
  • Nasdaq

    15,491.66
    -353.54 (-2.23%)
     
  • Russell 2000

    2,245.94
    -85.52 (-3.67%)
     
  • Crude Oil

    68.17
    -10.22 (-15.00%)
     
  • Gold

    1,792.30
    +8.00 (+0.45%)
     
  • Silver

    23.15
    -0.35 (-1.52%)
     
  • EUR/USD

    1.1306
    +0.0094 (+0.84%)
     
  • 10-Yr Bond

    1.4820
    -0.1630 (-9.91%)
     
  • GBP/USD

    1.3326
    +0.0006 (+0.05%)
     
  • USD/JPY

    113.6830
    -1.6560 (-1.44%)
     
  • BTC-USD

    54,982.15
    +712.37 (+1.31%)
     
  • CMC Crypto 200

    1,365.60
    -89.81 (-6.17%)
     
  • FTSE 100

    7,044.03
    -266.34 (-3.64%)
     
  • Nikkei 225

    28,751.62
    -747.68 (-2.53%)
     

U.S. administers over 411 mln doses of COVID-19 vaccines - CDC

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Oct 21 (Reuters) - The United States has administered 411,010,650 doses of COVID-19 vaccines in the country as of Thursday morning and distributed 498,702,405 doses, the U.S. Centers for Disease Control and Prevention said.

Those figures are up from the 410,189,737 vaccine doses the CDC said had gone into arms by Oct. 20 out of 496,915,265 doses delivered.

The agency said 219,624,445 people had received at least one dose while 189,924,447 people are fully vaccinated as of 6:00 a.m. ET on Thursday.

The CDC tally includes two-dose vaccines from Moderna and Pfizer/BioNTech , as well as Johnson & Johnson's one-shot vaccine.

About 11.6 million people have received a booster dose of either Pfizer, Moderna or Johnson & Johnson's COVID-19 vaccine. Booster doses from Moderna and Johnson & Johnson were authorized by the U.S. health regulator on Oct. 20. (Reporting by Amruta Khandekar in Bengaluru; Editing by Maju Samuel)